Patient-Centered Field Research in Medtech

Paul Charlebois and Eric Olson are seated across from each other at a white table in a modern office setting. The man on the left has curly brown hair and is wearing a light blue button-up shirt. He is smiling and looking toward the man on the right, who has short gray hair, glasses, and is wearing a dark patterned shirt with a small microphone clipped to his collar. The background is a bright, blurred open-plan office with desks and chairs, creating a soft focus effect behind the subjects. A blue pen and a blurred stack of folders or documents are on the table in the foreground.
Resources

Patient-Centered Field Research in Medtech

Sector: Surgical
YouTube video thumbnail

In this Before the Build episode, Eric Olson and Paul Charlebois reflect on the value of patient-centered field research—and how firsthand observation can reframe design priorities and impact outcomes in profound ways.

Paul shares an eye-opening story from a research session observing Mohs surgery, a specialized outpatient procedure for removing skin cancer. At first glance, the experience seemed overwhelming: patients were marked with dotted lines, then underwent facial excisions that appeared disfiguring. But over the course of the day, something deeper unfolded. The real story wasn’t just the clinical effectiveness of the surgery, but how patients experienced care, recovery, and dignity throughout the process.

The team observed how the clinic balanced harsh realities—patients with visible, temporary facial trauma waiting together in a shared space—with quiet, thoughtful design choices: no mirrors, careful pacing, and empathetic reconstruction work. These details emphasized the importance of viewing each case as more than a procedure.

Why Patient-Centered Field Research Matters

As Eric and Paul discuss, patient-centered field research often reveals more than what a design spec or user survey ever could. When engineers and developers step into real clinical environments, they can witness the emotional and procedural nuances that define patient experience. This approach can ultimately lead to better market adoption, stronger user satisfaction, and more impactful innovation.

Even when your device isn’t central to the treatment itself, being present in the broader clinical journey gives design teams critical insight into where they can reduce friction and add value.

Enjoying Before the Build? Sign up to get new episodes sent to your inbox.

Subscribe to MedTech Insights
Businessman holding a glowing compliance icon with legal and regulatory symbols, representing REACH SVHC compliance for medical device manufacturers

MPO: REACH SVHC Compliance for Medical Device Makers

Nigel Syrotuck breaks down REACH SVHC compliance for teams working with material suppliers and compliance questionnaires.

Medical Device Design Simulation

MD+DI: Medical Device Simulation Strategy That Works

We examine when computational modelling and simulation, or CM&S, genuinely supports medical device simulation strategy and when it becomes a costly detour.

Transparent medical device prototype surrounded by computational simulation mesh representing modeling and simulation during medical device development.

Building Better Medical Devices Faster: The Strategic Role of CM&S

Many teams still underuse CM&S, often bringing it late in device validation, when key decisions have already been made. That approach leaves much of the value of CM&S untapped.

Biomedical engineer reviewing a thermal simulation of human head tissue on a monitor, color-mapped from warm to cool gradients

Bioheat Transfer in Living Tissue: History, Models, and Engineering Applications

This article traces the Pennes bioheat equation from its 1948 origins to modern multiscale approaches, explaining how engineers select the right level of modelling complexity across device categories.